Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma.
- DOI
- 10.1038/s41375-026-03078-y
- Published
- 2026 Oct
- Container
- Leukemia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-026-03078-y,
title = {Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma.},
author = {Zhong L and Wang Q and Xian M and Qian J and Zhang C and Wu W and Guo Q and Zhang Y and Duan R and Zu Y and Mathur S and Orlowski RZ and Zhan F and Yi Q},
year = {2026},
journal = {Leukemia},
doi = {10.1038/s41375-026-03078-y},
url = {https://doi.org/10.1038/s41375-026-03078-y}
}RIS
TY - JOUR TI - Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma. AU - Zhong L AU - Wang Q AU - Xian M AU - Qian J AU - Zhang C AU - Wu W AU - Guo Q AU - Zhang Y AU - Duan R AU - Zu Y AU - Mathur S AU - Orlowski RZ AU - Zhan F AU - Yi Q PY - 2026 JO - Leukemia DO - 10.1038/s41375-026-03078-y UR - https://doi.org/10.1038/s41375-026-03078-y ER -
APA
L, Z., Q, W., M, X., J, Q., C, Z., W, W., Q, G., Y, Z., R, D., Y, Z., S, M., RZ, O., F, Z., & Q, Y. (2026). Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma.. Leukemia. https://doi.org/10.1038/s41375-026-03078-y
Source records
- pubmed · retrieved 2026-09-26T03:03:20.024Z